Overview

Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease

Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
A Phase 1 study designed to evaluate imaging characteristics of flortaucipir in the preclinical, prodromal and dementia phases of Alzheimer's disease.
Phase:
Phase 1
Details
Lead Sponsor:
Avid Radiopharmaceuticals